replacing white breads/pastas with whole grains, and adding foods such as flaxseeds and chia seeds to your diet
One should not use AOD-9604 if they: Are pregnant or breastfeeding Are a minor Have a current or recent history of cancer (particularly hormone-sensitive cancers) Have uncontrolled diabetes or significant insulin resistance Have active thyroid disease that is not well-managed Are taking medications that may interact with peptide therapy (discuss with your provider) Have a known hypersensitivity to peptide compounds Comprehensive labs including metabolic panel, fasting glucose, HbA1c, thyroid panel, lipid panel, and hormone levels should be run before starting any peptide therapy and monitored regularly throughout
The safety findings were more informative than the efficacy data
Data was self-reported by 1,412 surveyed customers who checked in with their provider on their second check-in between 4/1/23 and 4/1/24
Product Overview 5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in NAD+ metabolism and cellular energy regulation
All tests are processed through accredited UK labs, and results are interpreted to help guide peptide selection or dosing for those conducting experimental or educational research